From: Cardiovascular disease (CVD): assessment, prediction and policy implications
Years | Original Data | NDGM | Cumulative | RGR | RGR Mean | Dt | Mean Dt |
---|---|---|---|---|---|---|---|
2005 | 38,572 | 38,572 | 38,572 | Â | Â | Â | Â |
2006 | 38,317 | 38,716 | 76,889 | 0.690 | 0.208 | 1.064 | 2.464 |
2007 | 38,053 | 37,881 | 114,943 | 0.402 | Â | 1.604 | Â |
2008 | 37,525 | 37,151 | 152,469 | 0.283 | Â | 1.957 | Â |
2009 | 36,792 | 36,513 | 189,262 | 0.216 | Â | 2.225 | Â |
2010 | 35,644 | 35,955 | 224,907 | 0.173 | Â | 2.450 | Â |
2011 | 35,642 | 35,467 | 260,550 | 0.147 | Â | 2.552 | Â |
2012 | 35,070 | 35,041 | 295,620 | 0.126 | Â | 2.562 | Â |
2013 | 34,559 | 34,668 | 330,180 | 0.111 | Â | 2.615 | Â |
2014 | 33,961 | 34,342 | 364,141 | 0.098 | Â | 2.901 | Â |
2015 | 33,768 | 34,057 | 397,909 | 0.089 | Â | 3.106 | Â |
2016 | 33,710 | 33,808 | 431,619 | 0.081 | Â | 3.232 | Â |
2017 | 34,163 | 33,590 | 465,783 | 0.076 | Â | 3.305 | Â |
2018 | 33,399 | 33,410 | 33,399 | 0.286 | Â | 2.597 | Â |
2019 | 33,233 | 33,521 | 66,633 | 0.102 | Â | 2.751 | Â |
2020 | Â | 33,087 | 99,721 | Â | Â | Â | Â |
2021 | Â | 32,960 | 132,681 | 0.321 | 0.254 | 2.100 | 2.893 |
2022 | Â | 32,849 | 165,530 | 0.221 | Â | 2.765 | Â |
2023 | Â | 32,751 | 198,282 | 0.381 | Â | 2.864 | Â |
2024 | Â | 32,666 | 230,949 | 0.253 | Â | 2.943 | Â |
2025 | Â | 32,592 | 263,542 | 02132 | Â | 3.764 | Â |
2026 | Â | 32,527 | 296,069 | 0.116 | Â | 3.888 | Â |
2027 | Â | 32,470 | 328,540 | 0.304 | Â | 3.978 | Â |
MAPE % | Â | 2.02% | Â | Â | Â | Â | Â |